Skip to content

A Comparison of Multidetector CT and TE in the Diagnosis of Congenital Cyanotic Heart Diseases

A Comparison of Multidetector Computed Tomography and Transthoracic Echocardiography in the Diagnosis of Congenital Cyanotic Heart Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06749548
Enrollment
122
Registered
2024-12-27
Start date
2024-03-01
Completion date
2025-03-02
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

Multi-detector computed tomography angiography (MDCTA) provides high-resolution images of the heart and its vasculature, allowing for accurate anatomical assessment, detection of complex cardiac morphology,

Detailed description

evaluation of coronary artery anatomy, and identification of extracardiac anomalies including the coronaries, pulmonary arteries, aorta, and pulmonary or systemic veins, and it delineates vessel walls and also displays the airway, mediastinal abnormalities, and pulmonary parenchyma by using contrast media. This modality is particularly useful for evaluating complex cardiac anatomy and identifying potential surgical or interventional targets.

Interventions

RADIATIONGroup 1

the study is to emphasize the role of Computed Tomography Angiography (MDCTA) and Transthoracic Echocardiography (Echo) in the diagnosis of congenital cyanotic heart diseases.

Sponsors

Superior University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* age above 18 and less than 65. * having Congenital Cyanotic Heart Diseases

Exclusion criteria

* heart surgery * other heart issues * not consented

Design outcomes

Primary

MeasureTime frameDescription
Computed Tomgraphy Angiogrpahy12 MonthsAll patients will undergo MDCT using a 128-slice scanner. A contrast agent will be administered to visualize the heart's vascular structures. Detailed images of the heart's chambers, major blood vessels, and defects will be acquired

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026